MECP2 and Rett syndrome: Notably, approximately 35–40% of RTT-patients carry nonsense mutations, in which a premature termination codon (PTC) arises in the MECP2 mRNA, leading to the generation of a truncated and nonfunctional MeCP2 protein [7,8].